Achillion to Present at the Leerink Partners 5th Annual Global Healthcare Conference
February 08 2016 - 4:05PM
Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN)
announced today that Milind Deshpande, Ph.D., President and Chief
Executive Officer of Achillion, will present a corporate overview
at the Leerink Partners 5th Annual Global Healthcare Conference on
Thursday, February 11, 2016, at 11:35 a.m. ET at the Waldorf
Astoria Hotel in New York, NY.
The live audio and subsequent archived webcasts
of the Company's presentations will be accessible from the
Company's investor relations website, http://ir.achillion.com. The
audio recording will be archived for 30 days following the live
presentation. Please connect to Achillion's website several minutes
prior to the start of the presentation to ensure adequate time for
any software downloads that may be necessary.
About Achillion
Pharmaceuticals
Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) is
a science-driven, patient-focused company seeking to leverage its
strengths across the continuum from discovery to commercialization
in its goal of providing better treatments for people with serious
diseases. The company seeks to employ a highly-disciplined
discovery and development approach that has allowed it to pursue
best-in-class oral antiviral therapy for chronic hepatitis C (HCV)
and build a platform of potent and specific complement inhibitors.
Achillion is rapidly advancing its efforts to become a
fully-integrated pharmaceutical company with a goal of bringing
life-saving medicines to patients with rare diseases. More
information is available at http://www.achillion.com.
Investors:Glenn SchulmanAchillion Pharmaceuticals,
Inc.Tel. (203) 752-5510gschulman@achillion.com |
Media:Liz
PowerAchillion Pharmaceuticals, Inc.Tel: (203)
752-5509lpower@achillion.com |
Achillion Pharmaceuticals (NASDAQ:ACHN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Achillion Pharmaceuticals (NASDAQ:ACHN)
Historical Stock Chart
From Apr 2023 to Apr 2024